Table 6.
Clinicopathological characteristics of patients who underwent prophylactic mastectomies (n = 51)
| Age | |
| Mean | 43.7 |
| Median | 43 |
| Range | 30–62 |
| BRCA1 | |
| Positive | 29 cases |
| BRCA2 | |
| Positive | 18 cases |
| BRCA1/2 | |
| Negative | 4 cases |
| Breast cancer stage | |
| 0 | 3 cases |
| 1 | 17 cases |
| 2 | 14 cases |
| 3 | 4 cases |
| 4 | 0 case |
| Non-onset | 2 cases |
| Uncertain | 11 cases |
| Breast cancer subtype | |
| Hormone positive | |
| HER2 negative | 11 cases |
| HER2 positive | 3 cases |
| HER2 uncertain | 8 cases |
| Hormone negative | |
| HER2 positive | 0 case |
| HER2 negative | 23 cases |
| HER2 uncertain | 2 cases |
| Non-onset | 2 cases |
| Uncertain | 2 cases |
HER2 human epidermal growth factor receptor 2